Stockholders Re-Elect All Seven LifeVantage Incumbent Directors at Fiscal Year 2024 Annual Meeting
13 Novembre 2023 - 1:30PM
LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the
“Company”), a leading health and wellness company with products
designed to activate optimal health processes, today announced the
final, certified results of its fiscal year 2024 annual meeting of
stockholders (the “Annual Meeting”), as provided to the Company by
the independent inspector of elections. The results confirm that
stockholders re-elected all seven of the Company’s incumbent
directors.
LifeVantage issued the following statement:
The LifeVantage Board and management
team thank LifeVantage stockholders for their engagement and
attention to this Annual Meeting. The turnout was much higher than
at previous LifeVantage annual stockholder meetings, and we
appreciate the time it took for stockholders to understand the
issues this year and cast informed votes.
We have learned a lot by engaging
with our stockholders in this process, and very much value the
perspectives that have been expressed. We appreciate the support
stockholders – from the largest institutional investors in the
country to smaller, individual investors – have shown for our
directors.
We know we have more work to do, but
we are confident that we have the right Board and leadership team
to continue executing our LV360 strategy and deliver profitable
growth and significant value for our stockholders.
The results also confirm that stockholders
approved all other proposals presented at the Annual Meeting,
including our stockholders rights plan.
The certified results will be reported on an
amended Form 8-K filed with the U.S. Securities and Exchange
Commission.
Vinson & Elkins LLP served as legal counsel
and Spotlight Advisors, LLC served as financial and strategic
advisor to LifeVantage in this matter.
About LifeVantage
Corporation
LifeVantage Corporation (Nasdaq: LFVN), the
activation company, is a pioneer in nutrigenomics, the study of how
nutrition and naturally occurring compounds affect human genes to
support good health. The Company engages in the identification,
research, development, formulation and sale of advanced
nutrigenomic activators, dietary supplements, nootropics, pre- and
pro-biotics, weight management, skin and hair care, bath &
body, and targeted relief products. The Company’s line of
scientifically-validated dietary supplements includes its flagship
Protandim® family of products, LifeVantage® Omega+, ProBio, IC
Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary
supplements, the TrueScience® line of skin, hair, bath & body,
and targeted relief products. The Company also markets and sells
Petandim®, its companion pet supplement formulated to combat
oxidative stress in dogs, Axio® its nootropic energy drink mixes,
and PhysIQ, its smart weight management system. LifeVantage was
founded in 2003 and is headquartered in Lehi, Utah. For more
information, visit www.lifevantage.com.
Cautionary Note Regarding Forward
Looking Statements
This document contains forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words and
expressions reflecting optimism, satisfaction or disappointment
with current prospects, as well as words such as “believe,” “will,”
“hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,”
“anticipates,” “look forward to,” “goal,” “may be,” and variations
thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. The
declaration and/or payment of a dividend during any quarter
provides no assurance as to future dividends, and the timing and
amount of future dividends, if any, could vary significantly in
comparison both to past dividends and to current expectations.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding executing against and the benefits
of our key initiatives, future growth, including geographic and
product expansion, the impact of COVID-19 on our business, expected
financial performance, and expected dividend payments in future
quarters. Such forward-looking statements are not guarantees of
performance and the Company’s actual results could differ
materially from those contained in such statements. These
forward-looking statements are based on the Company’s current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company’s actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, further deterioration to
the global economic and operating environments as a result of
future COVID-19 developments, as well as those discussed in greater
detail in the Company’s Annual Report on Form 10-K and the
Company’s Quarterly Report on Form 10-Q under the caption “Risk
Factors,” and in other documents filed by the Company from time to
time with the U.S. Securities and Exchange Commission (the “SEC”).
The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR(646) 277-1260reed.anderson@icrinc.com
Media Relations Contact:
Dan McDermott, ICRDan.McDermott@icrinc.com
Grafico Azioni Lifevantage (NASDAQ:LFVN)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Lifevantage (NASDAQ:LFVN)
Storico
Da Mag 2023 a Mag 2024